Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.120
+0.180 (4.57%)
At close: Jul 17, 2026, 4:00 PM EDT
4.121
+0.001 (0.02%)
After-hours: Jul 17, 2026, 7:58 PM EDT
Aquestive Therapeutics Employees
Aquestive Therapeutics had 147 employees as of December 31, 2025. The number of employees increased by 5 or 3.52% compared to the previous year.
Employees
147
Change (1Y)
5
Growth (1Y)
3.52%
Revenue / Employee
$341,980
Profits / Employee
-$468,782
Market Cap
516.92M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 147 | 5 | 3.52% |
| Dec 31, 2024 | 142 | 7 | 5.19% |
| Dec 31, 2023 | 135 | 5 | 3.85% |
| Dec 31, 2022 | 130 | -27 | -17.20% |
| Dec 31, 2021 | 157 | -30 | -16.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evotec SE | 4,526 |
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 1,976 |
| Canopy Growth | 1,128 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 462 |
| Glass House Brands | 426 |
AQST News
- 12 days ago - Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism - GlobeNewsWire
- 23 days ago - Aquestive Therapeutics files to sell 230,271 shares of common stock for holders - TheFly
- 23 days ago - Aquestive Therapeutics Registration statement: Registration filing - Filings
- 5 weeks ago - Aquestive Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - Aquestive Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Aquestive Therapeutics Earnings release: Q1 2026 - Filings
- 2 months ago - Aquestive Therapeutics Quarterly report: Q1 2026 - Filings
- 2 months ago - Aquestive Therapeutics Slides: Q1 2026 - Filings